Skip to main content
. 2023 Sep 8;9:73. doi: 10.1038/s41523-023-00579-2

Table 3.

Response outcomes (n = 52).

Outcomes Patients
Overall objective response, n (%) [95% CI]

22 (42.3)

[28.9–55.7]

Complete response, n (%) 3 (5.8)
Partial response, n (%) 19 (36.5)
Stable disease, n (%) 10 (19.2)
Progressive disease, n (%) 16 (30.8)
Patients who had missing data or could not be evaluated, n (%) 4 (7.7)
Median duration of response (95% CI); months 12.7 [4.1–21.4]
Median cycle to best response (95% CI); months 3.0 (1–7)